Cornerstones, friends help Fosun cover IPO
Fosun Pharmaceutical had covered its Hong Kong IPO when it closed the books on Monday night and was expected to price at the bottom of its price range. But rival bankers were sceptical about the demand and where it came from, raising concerns about the aftermarket performance.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts